个人证件照

姓名: 吴亮 职称:副教授 硕士生导师电子邮件 :wl_ujs@163.com; wlujs@ujs.edu.cn
系所(中心):医学检验系
个人简介:吴亮,博士,江苏大学副教授、硕士生导师,长期从事医学检验教学与科研工作。2012年博士毕业后留校任教。主要研究肠道菌群与宿主代谢互作,聚焦糖尿病及其并发症、脂肪肝和动脉粥样硬化的早期诊断与干预。结合微生物组学、代谢组学及生物信息学,开展生物标志物筛选、中药与功能性食品干预研究。已发表论文130余篇,承担国家自然科学基金、中国博士后科学基金面上及特别资助等多项课题,注重基础研究与临床转化。
教育经历:
2009年9月—2012年6月 江苏大学 临床检验诊断学 博士研究生
2006年9月—2009年6月 江苏大学 临床检验诊断学 硕士研究生
2001年9月—2006年6月 江苏大学 医学检验 本科
研究方向:
1. 肠道菌群与宿主代谢互作机制:研究短链脂肪酸、胆汁酸及色氨酸代谢在糖尿病及其并发症、脂肪肝和动脉粥样硬化中的作用。
2. 慢性病早期诊断标志物筛选:整合微生物组学、代谢组学与生物信息学,筛选与慢性炎症及肝肾损伤相关的生物标志物。
3. 靶向肠道微生态的干预与转化研究:探索中药、益生菌及功能性食品调节肠道微生态、改善代谢紊乱和炎症损伤的机制与应用。
教学方向:病原生物学
教学奖励:
科研奖励:
科研项目:
1. 市级重点实验室建设项目,江苏大学盐城临床医学院分子医学研究中心(盐卫规划[2024]12号)。(合作单位负责人)
2. 扬州市基础研究计划(联合专项)卫生健康类项目,基于“肠-血管轴”采用益生菌疗法早期干预动脉粥样硬化发生并筛选新型诊断标志物的研究(项目编号:2024-2-24)。(合作单位负责人)
3. 江苏省中医药科技发展计划项目(项目编号:MS2022126),基于“肠道菌群-代谢物-免疫”轴研究小檗碱经SCFA改善高血脂患者体内炎症反应机制。(合作单位负责人)
4. 盐城市卫生健康委科研项目(项目编号:YK2024116),基于UPLC-MS/NS技术检测肠道来源短链脂肪酸用于“肠-代谢物-炎症”轴治疗动脉粥样硬化研究。(合作单位负责人)
5. 盐城市卫生健康委科研项目(项目编号:YK2024120),大黄活性成份增加肠道中SCFAs生成经“肠-肾轴”调控线粒体自噬治疗糖尿病肾病研究(YK2024120)。(合作单位负责人)
出版专著:
出版教材:
发表论文:
[1] Wu L*, Dong X, Sun W, Xu H, Xie Y, Liu X, Liu X, Ali A, Shao K*. D-Psicose Attenuates Hepatic Steatosis and Inflammatory Injury in HFD/STZ-Induced T2DM Mice and Is Associated With Alterations in Gut Microbiota, Tryptophan Metabolism, and Hepatic AhR-Related Signaling. Food Sci Nutr. 2026;14(10):e72455. doi: 10.1002/fsn3.72455. 〔JCR:Q2;IF:5.0〕
[2] Li N, Sun W, Liu X, Liu X, Xie Y, Xu H, Xu L, Zang J, Zhang L, Wu L*, Shao K*. Network Pharmacology-Based Prediction and In Vivo Validation of Fumonisin B1-Induced Liver Injury and Early Fibrosis. J Biochem Mol Toxicol. 2026;40(10):e71129. doi: 10.1002/jbt.71129. 〔JCR:Q2;IF:3.6〕
[3] Ali A*, Eid H, Moazen EM, Qutp SF, El Naggar BMA, Elzomor HM, Esmail MMA, Elmesiry AM, Elazab SA, Raafat MA, Abdelrahman EK, Wu L*, Alghulayqah A, Saleh MM, Elfeky SEF, Eissa AM, Abdelmoneam SH. Diagnostic accuracy of shear wave elastography and ultrasound-derived indices in interstitial lung disease: novel insights into connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis. Egypt J Bronchol. 2026 Sep 18;20:166. doi: 10.1186/s43168-026-00678-1. 〔JCR:Q4;IF:0.6〕
[4] Guo D, Xie J, Dong X, Xu H, Xie Y, Liu X, Xu L, Ali A, Chen M, Zhang L, He J, Wu L*, Shao K*. Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan–Kynurenine Metabolic Pathway. J Immunol Res. 2026 Sep 14;2026:1020462. doi: 10.1155/jimr/1020462.〔JCR:Q3;IF:3.2〕
[5] Ali A*, Wu L*, Elfeky S, Moazen EM, Elshormilisy AA, Eissa AM, Abdelmoneam SH, Elfeqy MEAH, Elsheikh MS, Ibrahim DA. Metabolic syndrome in chronic obstructive pulmonary disease: paradoxical relationships between systemic inflammation, oxygenation, and lipid profiles with implications for one-year clinical outcomes. The Egyptian Journal of Bronchology. 2026 Aug 13;20:134. doi: 10.1186/s43168-026-00644-x.〔JCR:Q4;IF:0.6〕
[6] Chen W, Li L, Dong X, Xu H, Zheng C, Zhang B, Lu W, Ma X, Li N, Xia W, Ali A, Wu L*, Chen Y. Hawthorn flavonoids ameliorate NAFLD in mice: Association with enhanced gut butyrate production and hepatic PI3K/Akt signaling activation. ScienceAsia. 2026 May 5;52(2):1-12. doi: 10.2306/scienceasia1513-1874.2026.037.〔JCR:Q3;IF:0.9〕
[7] Shao K, Cao Y, Gao R, Dong X, Liu X, Xu H, Xie Y, Xu L, He J, Chen M, Zhang L, Ali A, Wu L*, Wang P. Virgin Coconut Oil Attenuates Diabetic Kidney Disease via Gut Microbiota-Metabolism-Inflammation Axis Modulation in Type 2 Diabetic Mice. Food Sci Nutr. 2026 Jun 11;14(6):e71973. doi: 10.1002/fsn3.71973.〔JCR:Q2;IF:5.0〕
[8] Wang P, Liu X, Sun W, Dong X, Tan J, Chen M, He J, Ali A, Wu L*, Shao K*. Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease. J Diabetes Res. 2026;2026(1):e2131566. doi: 10.1155/jdr/2131566.〔JCR:Q2;IF:3.5〕
[9] Xu D, Qiu B, Dong X, Tan J, Xie Y, Wan Y, Chu C, Miao C, Ali A, Chen M, He J, Wu L*, Xie J*. Multi-Target Mechanisms of Whey Protein Against NAFLD: Integrating Bile Acid Metabolism, Gut Microbiota and Hepatic Inflammation. Food Sci Nutr. 2026 Mar 16;14(3):e71655. doi: 10.1002/fsn3.71655.〔JCR:Q2;IF:5.0〕
[10] Xu H, Liu X, Sun W, Dong X, Liu X, Xie Y, He J, Ali A, Chen M, Wu L*, Ma J*, Shao K*. Multi-omics elucidation of Lactiplantibacillus plantarum NKK20 in preventing PCOS via the gut-ovary axis: SCFAs-mediated microbiota-metabolite-immune crosstalk. Front Nutr. 2026 Jan 15;12:1709581. doi: 10.3389/fnut.2025.1709581.〔JCR:Q1;IF:5.5〕
[11] Dong X, Sun W, Xu H, Xie Y, He J, Liu X, Liu X, Ali A, Chen M, Zhang L, Wu L*, Shao K*. Ursodeoxycholic acid alleviates high-fat diet-induced liver injury by modulating gut microbiota-mediated bile acid metabolism: an integrated microbiota-metabolomics analysis. Front Nutr. 2026 Jan 26;13:1714100. doi: 10.3389/fnut.2026.1714100.〔JCR:Q1;IF:5.5〕
[12] 高蕊琪, 孙文, 谭家骏, 董雪云, 马洁, 吴亮*, 王平平. 基于肠道菌群和血清代谢组学探讨蝶豆花减轻非酒精性脂肪肝小鼠肝脏损伤的机制[J]. 江苏大学学报(医学版), 2026, 36(1):9–16.
[13] Sun W, Wang P, Jingwen X, Jiayuan H, Ali A*, Wu L*. (2025). The effects of oral probiotics quadruple live bacteria tablets on the serum non-targeted metabolomics of mechanically ventilated patients. The Egyptian Journal of Bronchology, 19(1), 126.〔JCR:Q4;IF:0.6〕
[14] Ali, A.*, Wu, L.*, Moazen, E. M., Gaber, F., Ezzat Fathy Elfeky, S., Elsheikh, M. S. (2025). When diet matters: the role of proinflammatory and anti-inflammatory diets in post-COVID-19 fatigue. The Egyptian Journal of Internal Medicine, 37(1), 156.〔JCR:Q2;IF:1.2〕
[15] Wu L*, Dong X, Sun W, Jiajun T, Ali A, He J, Wang P*. Hydroxysafflor yellow A alleviates oxidative stress and inflammatory damage in the livers of mice with nonalcoholic fatty liver disease and modulates gut microbiota. Front Pharmacol. 2025 Jun 6;16:1568608. doi: 10.3389/fphar.2025.1568608.〔JCR:Q1;IF:5.4〕
[16] Jiang F, Huang X, Yan M, Tan J, Dong X, Liu X, He J, Ali A, Chen M, Zhang L, Wu L*, Wang P*. Mogrosides protect against diabetic kidney injury via inhibiting macrophage activation in a mouse model. J Diabetes Res. 2025 Jun 24;2025:5291562. doi: 10.1155/jdr/5291562.〔JCR:Q2;IF:3.5〕
[17] Wu L*, Tan J, Sun W, Dong X, He J, Ali A, Chen M, Zhang L, Wang P*. Network pharmacology and serum nontargeted metabolomics reveal the protective effects of propionate against liver damage induced by a high-fat and AGE-rich diet in diabetic mice. J Diabetes Res. 2025 Jul 2;2025:3955893. doi: 10.1155/jdr/3955893.〔JCR:Q2;IF:3.5〕
[18] Tan J, Sun W, Dong X, He J, Ali A, Chen M, Zhang L, Wu L*, Shao K*. D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress. Front Nutr. 2025 May 27;12:1574151. doi: 10.3389/fnut.2025.1574151.〔JCR:Q1;IF:5.5〕
[19] Guangzhou Wang, Lin Zhou, Zhengfang Wang, Asmaa Ali*, Liang Wu*. Palmitoleic and oleic fatty acids as biomarkers for coronary heart disease: A predictive model. Irish Journal of Medical Science. 2025;194(1):59–70. doi:10.1007/s11845-024-03839-7.〔JCR:Q2;IF:2.0〕
[20] Ma P, Sun W, Sun C, Tan J, Dong X, He J, Ali A, Chen M, Zhang L, Wu L*, Wang P. Using gut microbiota and non-targeted metabolomics techniques to study the effect of xylitol on alleviating DSS-induced inflammatory bowel disease in mice. BMC Immunol. 2025 Mar 10; 26(1):18. doi: 10.1186/s12865-025-00700-z.〔JCR:Q3;IF:2.9〕
[21] Xiaoli Huang, Wen Sun, Chang Sun, Jiajun Tan, Liang Wu*, Fumeng Yang. Effects of Ethanol Extract from Senna Leaf (EESL) on Inflammation and Oxidative Stress in Mice: A Non-targeted Metabolomic Study. Endocrine, Metabolic & Immune Disorders – Drug Targets. 2025;25(9):695–709. doi:10.2174/0118715303325372241014152811.〔JCR:Q3;IF:2.0〕
[22] 谭家骏, 孙文, 董雪云, 和佳鸳, 王平平, 吴亮*. 丁酸钠激活自噬改善油酸和AGEs诱导的肝细胞脂质沉积和炎症反应[J]. 江苏大学学报(医学版), 2025, 35(3):191–196,211. doi:10.13312/j.issn.1671-7783.y240143.
[23] Jiayuan He, Xiang Li, Man Yan, Xinsheng Chen, Chang Sun, Jiajun Tan, Yinsheng Song, Hong Xu, Liang Wu*, Zhengnan Yang. Inulin reduces kidney damage in type 2 diabetic mice by decreasing inflammation and serum metabolomics. J Diabetes Res. 2024, 2024:1222395.〔JCR:Q2;IF:3.5〕
[24] Xiajun Zhang, Jingwen Xu, Xueyun Dong, Jiajun Tang, Yan Xie, Jie Yang, Limin Zou, Liang Wu*, Jilong Fan. Bifidobacterium longum BL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. Food Science & Nutrition. 2024;12(9):6442–6460. doi:10.1002/fsn3.4279.〔JCR:Q2;IF:5.0〕
[25] Asmaa Ali, Liang Wu*, Sameh Samir Ali. Vitamin D and the microbiota connection: understanding its potential to improve COPD outcomes. The Egyptian Journal of Bronchology. 2024, 18:20.〔JCR:Q4;IF:0.6〕
[26] Seham Ezzat Fathy Elfeky, Asmaa Ali, Eman M. Moazen, Mohammad Hamad Alhassoon, Nesma A. Elzanaty, Nouf Mubarak Alazmi, Liang Wu*, Mai M. Saleh. Systemic inflammatory response index as an independent predictor of severity in patients with obstructive sleep apnea. The Egyptian Journal of Bronchology. 2024, 18:1.〔JCR:Q4;IF:0.6〕
[27] Asmaa A. Ali, Rasha N. Yousef, Mai S. Elsheikh, Abeer R. Salamah, Liang Wu*. Wu, Alshaimaa R. Alnaggar, Noha M. Khalil, Mervat E. Behiry. YKL-40 in serum: a promising biomarker of juvenile SLE and strongly correlated with disease duration. Irish Journal of Medical Science. 2024;193:1403–1409. doi:10.1007/s11845-023-03545-w.〔JCR:Q2;IF:2.0〕
[28] Asmaa Ali, Liang Wu*, Sameh Samir Ali. Gut microbiota and acute kidney injury: immunological crosstalk link. Int Urol Nephrol. 2024 Apr;56(4):1345-1358.〔JCR:Q2;IF:2.2〕
[29] Shu Chen, Yue Xi, Hai Zhang, Sanrong Xu, Shengzhi Chen, Zhengnan Yang, Liang Wu*. Berberine alleviates 5-fluorouracil-Induced inflammatory response in macrophages and intestinal mucositis in mice. J. Biol. Regul. Homeost. Agents. 2024; 38(1): 263–275.
[30] Asmaa Ali, Wu Liang, Ahmed Samir Abdelhafiz, Mai M. Saleh, Heba Salem, Eman M. Moazen, Maram I. Elmazny, Mohammed Abdallah Rakha, Seham Ezzat Fathy Elfeky. Elevation of D-dimer levels are associated with early need for mechanical ventilation support in patients with COVID-19. BMC Pulm Med. 2023, 23(1):283.〔JCR:Q2;IF:3.1〕
[31] Xiaohong Sun, Yue Xi, Man Yan, Chang Sun, Jianjun Tang, Xueyun Dong, Zhengnan Yang, Liang Wu*. Lactiplantibacillus plantarum NKK20 increases intestinal butyrate production and inhibits type 2 diabetic kidney injury through PI3K/Akt pathway. J Diabetes Res. 2023, 2023:8810106.〔JCR:Q2;IF:3.5〕
[32] Chang Sun, Chenguang Qiu, Yanyan Zhang, Man Yan, Jiajun Tan, Jiayuan He, Dakai Yang, Dongxu Wang, Liang Wu*. Lactiplantibacillus plantarum NKK20 alleviates high-fat-diet-induced nonalcoholic fatty liver disease in mice through regulating bile acid anabolism. Molecules, 2023, 28(10):4042.〔JCR:Q2;IF:5.1〕
[33] Wu L*, Xi Y, Yan M, Sun C, Tan J, He J, Li H, Wang D. Berberine-based carbon quantum dots improve intestinal barrier injury and alleviate oxidative stress in C57BL/6 mice with 5-fluorouracil-induced intestinal mucositis by enhancing gut-derived short-chain fatty acids contents. Molecules, 2023, 28(5):2148.〔JCR:Q2;IF:5.1〕
[34] Yan M, Zhang YY, Xi Y, Ding LK, Sun C, Qu LJ, Qian X, Xu JW, Sun W, L Wu*. Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice. Acta Pharm, 2023, 73(1):121-132.〔JCR:Q3;IF:1.8〕
[35] Yi C, Sun W, Ding L, Yan M, Sun C, Qiu C, Wang D, L Wu*. Short-chain fatty acids weaken ox-LDL-induced cell inflammatory injury by inhibiting the NLRP3/Caspase-1 pathway and affecting cellular metabolism in THP-1 cells. Molecules, 2022, 27(24):8801.〔JCR:Q2;IF:5.1〕
[36] Man Yan, Xiang Li, Chang Sun, Jiajun Tan, Yuanyuan Liu, Mengqi Li, Zishang Qi, Jiayuan He, Dongxu Wang, Liang Wu*. Sodium butyrate attenuates AGEs-induced oxidative stress and inflammation by inhibiting autophagy and affecting cellular metabolism in THP-1 cells. Molecules, 2022, 27:8715.〔JCR:Q2;IF:5.1〕
[37] Xiaohong Feng, Longkun Ding, Guifang Ma, Ying Zhang, Yefu Sun, Zhengzhang Li, Xiaojun Tao, Asmaa Ali, Dongxu Wang, Liang Wu*. Lactobacillus rhamnosus TR08 improves dyslipidemia in mice fed with a high fat diet by regulating the intestinal microbiota, reducing systemic inflammatory response, and promoting sphingomholipid metabolism. Molecules, 2022, 27:7357.〔JCR:Q2;IF:5.1〕
[38] Dongxu Wang, Taotao Wang, Zhihong Zhang, Zhanming Li, Yuanxin Guo, Guangshan Zhao, Liang Wu*. Recent advances in the effects of dietary polyphenols on inflammation in vivo: potential molecular mechanisms, receptor targets, safety issues, and uses of nanodelivery system and polyphenol polymers. Current Opinion in Food Science. 2022;48:100921. doi:10.1016/j.cofs.2022.100921.〔JCR:Q1;IF:8.2〕
[39] Xi Yue, Sun Wen, Ding Long-kun, Yan Man, Sun Chang, Zhang Min, Li Shuang-yu, Qian Xin, Ma Jie, Wu Liang*. Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction. BMC Immunology. 2022, 23:19.〔JCR:Q3;IF:2.9〕
[40] Chen Shu, Zhang Yan-yan, Zhang Hai, Ding Long-kun, Xi Yue, Yan Man, Sun Chang, Wu Liang*, Hu Hao. Anti-inflammatory effects of NaB and NaPc in Acinetobacter baumannii-stimulated THP-1 cell via TLR-2/NF-κB/ROS/NLRP3 pathway. Acta Pharm. 2022, 72: 615-628.〔JCR:Q3;IF:1.8〕
[41] 丁龙坤, 席月, 闫曼, 杨大凯, 周林, 吴亮*. 不同浓度丁酸钠抑制氧化型低密度脂蛋白诱导THP-1细胞炎症反应的研究[J]. 新疆医科大学学报, 2022, 45(1):29–36.
会议与工作论文: